Completed research The clinical development program has generated substantial human data: Phase 1 safety studies in healthy volunteers Phase 2 trials in sarcoidosis with small fiber neuropathy Phase 2b trials evaluating corneal nerve regeneration Phase 2 trials in type 2 diabetes with neuropathy Multiple ophthalmic studies This represents significantly more human research than most peptides available to researchers
As a peptide stack recovery strategy, the combination may support complementary recovery pathways, potentially enhancing the bodys natural healing processes from multiple angles
Front Immunol (2019) 10:1027
To be honest, for the credibility of the research this is important context
Trusted Australia peptide supplier HPLC tested Multiple formulations Fast dispatch Research use only Which BPC-157 Formulation Should You Choose
Consequently, circumventing blockades, blood flow was restored, and pale areas without mucosal folds did not occur